GO:0000154 rRNA modification: Genes and Methods

Ribosomes are the cellular machines that translate mRNA into protein, and their RNA components are not static scaffolds but dynamically modified molecules. GO:0000154 rRNA modification is the biological process by which one or more nucleotides within an rRNA molecule are covalently altered, yielding an rRNA sequence that differs from the genetically encoded sequence. These modifications include methylation, pseudouridylation, acetylation and other chemical changes that expand the chemical repertoire of rRNA beyond the four standard bases. Because rRNA modification directly influences ribosome biogenesis, structure and translational fidelity, it has emerged as a central node in gene expression control. The importance of rRNA modification extends from basic ribosome biology to human disease. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression, demonstrating that a single rRNA modification can drive tumorigenesis. Dynamic 23S rRNA modification ho5C2501 benefits Escherichia coli under oxidative stress, illustrating how rRNA modification supports adaptation to environmental stress. Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures, suggesting that rRNA modification patterns can be exploited for diagnostics. Pan-modification profiling facilitates a cross-evolutionary dissection of the thermoregulated ribosomal epitranscriptome, showing that rRNA modification is responsive to temperature and has deep evolutionary roots. For researchers, GO:0000154 rRNA modification is both a mechanistic puzzle and a therapeutic opportunity. The process is catalyzed by dedicated enzymes and guided by small nucleolar RNAs or archaeal ribonucleoproteins, and its dysregulation is linked to cancer, ribosomopathies and stress responses. Understanding which nucleotides are modified, which enzymes install them, and how these marks change in disease requires integrated genetic, biochemical and computational approaches. This article provides a research-grade overview of GO:0000154 rRNA modification, its genes, functions, disease links and the CRISPR-based methods used to study it.

GO:0000154 rRNA modification is defined as the covalent alteration of one or more nucleotides within an rRNA molecule to produce an rRNA molecule with a sequence that differs from that coded genetically. In other words, the cell chemically edits its ribosomal RNA after transcription, adding groups such as methyl or acetyl moieties or isomerizing uridine to pseudouridine, so that the mature rRNA is not a faithful copy of the gene. This process is also known as rRNA editing.

rRNA modification is important because it directly shapes the ribosome, the machine that synthesizes every protein in the cell. Chemical marks on rRNA influence ribosome assembly, stability and translational output, and they can be dynamically regulated by environmental cues such as oxidative stress and temperature. In humans, dysregulated rRNA modification is linked to cancer: METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. rRNA modification patterns also carry tissue-of-origin and tumor-specific information, making them attractive biomarkers. Because these marks are installed by specific enzymes, they are genetically tractable and represent potential therapeutic targets.

The following genes and proteins are central to rRNA modification, based on published literature.

rRNA modification is regulated at multiple levels. Environmental cues such as temperature and oxidative stress dynamically alter rRNA modification patterns, as shown by pan-modification profiling of the thermoregulated ribosomal epitranscriptome and by ho5C2501 modification benefiting Escherichia coli under oxidative stress. The expression and activity of modifying enzymes such as METTL5 and METTL1 are also regulated, with METTL5-mediated 18S rRNA m6A modification promoting oncogenic translation in cancer and METTL1 regulating CDK14 mRNA stability in prostate cancer. Structural studies of m6A/m6Am methyltransferases reveal how enzyme architecture controls substrate recognition and catalytic activity. Together, these layers ensure that rRNA modification is responsive to cellular state and stress.

METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression, directly linking an rRNA modification enzyme to tumor growth. METTL1 regulates CDK14 mRNA stability via internal m7G modification in castration-resistant prostate cancer, showing that RNA methyltransferases can drive aggressive cancer phenotypes. Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures, suggesting that rRNA modification patterns could serve as cancer biomarkers. These findings position rRNA modification as a therapeutic and diagnostic target in oncology.

Because rRNA modification is essential for ribosome biogenesis and function, defects in this process can contribute to ribosomopathies, a group of disorders caused by impaired ribosome production. Tuning the ribosome through rRNA modification influences eukaryotic ribosome biogenesis and function, and perturbations can affect cell growth and development. Ribosomal protein genes such as RPS19, RPL5 and RPL11 are associated with ribosomopathy biology, and their functions intersect with rRNA modification pathways.

Dynamic 23S rRNA modification ho5C2501 benefits Escherichia coli under oxidative stress, demonstrating that rRNA modification supports bacterial survival under adverse conditions. Archaeal pre-rRNA processing and modification involve ribonucleoproteins, highlighting conserved mechanisms across evolution. These stress-adaptive roles suggest that targeting rRNA modification could influence microbial fitness and host-pathogen interactions.

Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures, enabling researchers to map rRNA modification patterns across samples. Pan-modification profiling facilitates a cross-evolutionary dissection of the thermoregulated ribosomal epitranscriptome, allowing systematic comparison of modification states under different conditions. These methods combine biochemical enrichment with sequencing or mass spectrometry to quantify rRNA marks.

Because rRNA modification influences translation, Ribo-seq can measure how changes in modification enzymes affect ribosome occupancy and translational output. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation, and translation profiling can reveal the downstream consequences of this mark. Tuning the ribosome through rRNA modification affects eukaryotic ribosome biogenesis and function, which can be assessed by polysome profiling and related techniques.

A comprehensive review of m6A/m6Am RNA methyltransferase structures provides a framework for biochemical and structural studies of rRNA-modifying enzymes. Archaeal pre-rRNA processing and modification studies use ribonucleoprotein biochemistry to dissect mechanism. Dynamic 23S rRNA modification ho5C2501 under oxidative stress was characterized using biochemical and genetic assays in Escherichia coli.

CRISPR knockout, point-mutation and knock-in models allow causal testing of rRNA modification genes. METTL5 knockout reduces 18S rRNA m6A and oncogenic translation, demonstrating the power of CRISPR in this field. METTL1 models in prostate cancer show how overexpression and loss-of-function can be used to study rRNA modification enzymes. These approaches can be combined with epitranscriptomic profiling to link genotype to modification phenotype.

Researchers studying rRNA modification-related genes often need to determine whether a candidate gene is causally involved in installing, removing or responding to specific rRNA marks. Establishing causality requires precise genetic models that can knockout, mutate, tag or overexpress the gene of interest, coupled with readouts of rRNA modification and translation.

GO:0000154 rRNA modification is a fundamental biological process that chemically diversifies rRNA and tunes ribosome function. It is catalyzed by dedicated enzymes such as METTL5 and METTL1, is dynamically regulated by stress and temperature, and is increasingly linked to cancer and ribosomopathies. Epitranscriptomic profiling and CRISPR models have made it possible to map rRNA marks and test their causal roles, opening new avenues for diagnostics and therapeutics. Continued research into rRNA modification will deepen our understanding of translation control and reveal new targets for disease intervention.